Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02
Go back to Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02| Aurum Resources Corp (NYSE: ARMP) | Delayed: 4.20 -0.06 (1.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.26 | 52 Week High | $2.00 | |||
| Open | $4.27 | 52 Week Low | $1.50 | |||
| Day High | $4.56 | P/E | N/A | |||
| Day Low | $4.14 | EPS | $0.00 | |||
| Volume | 128,344 | |||||
